688192 迪哲醫藥
按盤價 
43.820 +6.010 (+15.895%) | 2024/06 - 中期 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | -47.301 | -84.976 | -34.871 | -37.827 | -76.720 |
| 總資產報酬率 ROA (%) | -21.949 | -61.913 | -30.491 | -34.110 | -64.841 |
| 投入資產回報率 ROIC (%) | -26.963 | -71.379 | -33.498 | -36.913 | -76.716 | 邊際利潤分析 |
| 銷售毛利率 (%) | 97.656 | 96.478 | -- | 12.420 | 12.471 |
| 營業利潤率 (%) | -212.379 | -1,213.308 | -- | -6,512.850 | -2,112.991 |
| 息稅前利潤/營業總收入 (%) | -207.642 | -1,207.359 | -- | -6,441.487 | -2,014.226 |
| 淨利潤/營業總收入 (%) | -212.379 | -1,213.419 | -- | -6,512.850 | -2,113.094 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 108.813 | 104.851 | 106.708 | 101.841 | 134.946 |
| 價值變動淨收益/利潤總額(%) | -1.705 | -2.033 | -5.730 | -0.353 | -0.452 |
| 營業外收支淨額/利潤總額(%) | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 償債能力分析 |
| 流動比率 (X) | 1.871 | 2.030 | 5.928 | 9.964 | 6.062 |
| 速動比率 (X) | 1.812 | 1.978 | 5.908 | 9.964 | 6.062 |
| 資產負債率 (%) | 62.217 | 43.288 | 15.535 | 10.304 | 8.723 |
| 帶息債務/全部投入資本 (%) | 48.907 | 27.806 | 0.561 | 0.660 | 0.000 |
| 股東權益/帶息債務 (%) | 96.002 | 242.222 | 17,006.872 | 14,625.948 | -- |
| 股東權益/負債合計 (%) | 59.510 | 131.011 | 543.703 | 870.537 | 1,046.410 |
| 利息保障倍數 (X) | -43.839 | -202.965 | 90.190 | -90.264 | -20.394 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 62.673 | 189.449 | -- | 252.938 | 109.306 |
| 存貨周轉天數 (天) | 1,058.085 | 1,597.977 | -- | 0.000 | 0.000 |
| 備註： | 即時報價更新時間為 30/09/2024 16:29 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
